Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications-Reference-Cited by-同舟云学术

Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications

Published:1981 Issue:6 Volume:141 Page:539-546
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Ehrlich Clarence E.,Young Peter C.M.,Cleary Robert E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference40 articles.

1. Annual report of the results of treatment, Gynecol;Kottmeier;Cancer,1979

2. Gestagens and endometrial carcinoma, Gynecol;Kohorn;Oncol,1976

3. Nonhormonal chemotherapy of endometrial adenocarcinoma. A review;Donovan;Cancer,1974

4. Phase II trial of Adriamycin in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study, Cancer Treat;Thigpen;Rep,1979

5. Phase II trial of Adriamycin and cyclophosphamide. A Southwest Oncology Group Pilot Study;Lloyd;Proc. Am. Assoc. Cancer Res,1975

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system;The Journal of Steroid Biochemistry and Molecular Biology;2023-03

2. Adenocarcinoma of the uterine corpus and sarcomas of the uterus;DiSaia and Creasman Clinical Gynecologic Oncology;2023

3. The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis;BJOG: An International Journal of Obstetrics & Gynaecology;2022-11-13

4. Endometrial Cancer;Holland‐Frei Cancer Medicine;2022-10-21

5. YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinoma;2022-08-09